Skip to Content

FDA Approves Keppra Injection

Keppra Injection is an intravenous formulation of levetiracetam providing an alternative for patients when oral administration is temporarily not feasible. Keppra Injection is indicated for use as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy.

Posted: July 2006

Related Articles: